Skip to main content
. Author manuscript; available in PMC: 2014 Feb 22.
Published in final edited form as: Neurosci Lett. 2013 Jan 8;535:57–61. doi: 10.1016/j.neulet.2012.12.046

Figure 3.

Figure 3

Percent cell viability of mecamylamine + nicotine pre-treatment in N2a, N2a-APP695 and N2a-APPSweΔ9PS1 cells. Mecamylamine (uM) was added 2 hrs before nicotine (0.01 uM) treatment. MTT Assay was performed 72h following nicotine pre-treatment. Values are mean ± SEM, n=5. * P<0.05 **P<0.01, ***P<0.001 compared to nicotine 0.01uM.